Journal
SCIENCE
Volume 326, Issue 5956, Pages 1123-1127Publisher
AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.1175868
Keywords
-
Categories
Funding
- NIH
- International AIDS Vaccine Initiative
- Bill and Melinda Gates Foundation Grand Challenges in Global Heath Initiative
Ask authors/readers for more resources
The site on HIV-1 gp120 that binds to the CD4 receptor is vulnerable to antibodies. However, most antibodies that interact with this site cannot neutralize HIV-1. To understand the basis of this resistance, we determined co-crystal structures for two poorly neutralizing, CD4-binding site (CD4BS) antibodies, F105 and b13, in complexes with gp120. Both antibodies exhibited approach angles to gp120 similar to those of CD4 and a rare, broadly neutralizing CD4BS antibody, b12. Slight differences in recognition, however, resulted in substantial differences in F105- and b13-bound conformations relative to b12-bound gp120. Modeling and binding experiments revealed these conformations to be poorly compatible with the viral spike. This incompatibility, the consequence of slight differences in CD4BS recognition, renders HIV-1 resistant to all but the most accurately targeted antibodies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available